Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma

被引：0
|
作者：
Jordan Amdahl
Lei Chen
Thomas E. Delea
机构：
[1] Policy Analysis Inc. (PAI),
[2] Novartis Pharmaceuticals,undefined
来源：
Oncology and Therapy | 2016年 / 4卷 / 2期
关键词：
Clinical trials; Melanoma; Network meta-analysis;
D O I：
10.1007/s40487-016-0030-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：239 / 256
页数：17
相关论文
共 50 条
  • [1] Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
    Amdahl, Jordan
    Chen, Lei
    Delea, Thomas E.
    ONCOLOGY AND THERAPY, 2016, 4 (02) : 239 - 256
  • [2] Progression-free(PFS) and overall survival (OS) in treatment of BRAF mutation-positive metastatic melanoma: Bayesian network meta-analysis.
    Oh, Mok
    Almutairi, Abdulaali
    Alsaid, Nimer
    Babiker, Hani M.
    McBride, Ali
    Abraham, Ivo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia
    Ladyzynski, Piotr
    Molik, Maria
    Foltynski, Piotr
    CANCER TREATMENT REVIEWS, 2015, 41 (02) : 77 - 93
  • [4] A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression-free survival as a surrogate for overall survival
    Flaherty, K. T.
    Lee, S. J.
    Dummer, R.
    Hauschild, A.
    Hennig, M.
    Long, G. V.
    Lorigan, P.
    Robert, C.
    Schadendorf, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S856 - S856
  • [5] Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis
    Paoletti, Xavier
    Lewsley, Liz-Anne
    Daniele, Gennaro
    Cook, Adrian
    Yanaihara, Nozomu
    Tinker, Anna
    Kristensen, Gunnar
    Ottevanger, Petronella B.
    Aravantinos, Gerasimos
    Miller, Austin
    Boere, Ingrid A.
    Fruscio, Robert
    Reyners, Anna K. L.
    Pujade-Lauraine, Eric
    Harkin, Andrea
    Pignata, Sandro
    Kagimura, Tatsuo
    Welch, Stephen
    Paul, James
    Karamouza, Eleni
    Glasspool, Rosalind M.
    JAMA NETWORK OPEN, 2020, 3 (01)
  • [6] CABOZANTINIB VERSUS STANDARD-OF-CARE COMPARATORS: A NETWORK META-ANALYSIS OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN FIRST-LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA
    Lister, J.
    Pafitas, S.
    Meng, J.
    Wiecek, W.
    Schmidt, E.
    Zagorska, A.
    Marteau, F.
    VALUE IN HEALTH, 2019, 22 : S443 - S443
  • [7] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Chirila, Costel
    Odom, Dawn
    Devercelli, Giovanna
    Khan, Shahnaz
    Sherif, Bintu N.
    Kaye, James A.
    Molnar, Istvan
    Sherrill, Beth
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (05) : 623 - 634
  • [8] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Costel Chirila
    Dawn Odom
    Giovanna Devercelli
    Shahnaz Khan
    Bintu N. Sherif
    James A. Kaye
    István Molnár
    Beth Sherrill
    International Journal of Colorectal Disease, 2012, 27 : 623 - 634
  • [9] INVESTIGATING PROGRESSION-FREE SURVIVAL AS A POTENTIAL SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN FIRST-LINE TREATMENT FOR GLIOBLASTOMA MULTIFORME: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Fu, A.
    Fazeli, M. S.
    Kanters, S.
    Siliman, G.
    Ma, Chaudhary
    Gogate, A.
    Kurt, M.
    VALUE IN HEALTH, 2020, 23 : S4 - S4
  • [10] A quantitative study of tumor response and progression-free survival as surrogate endpoints for overall survival in first-line treatment of metastatic breast cancer
    Burzykowski, T
    Piccart, MJ
    Sledge, G
    Carmichael, J
    Luck, HJ
    Mackey, JR
    Nabholtz, JM
    Paridaens, R
    Biganzoli, L
    Jassem, J
    Blohmer, JU
    Bontenbal, M
    Bonneterre, J
    Chan, S
    Atalay, G
    Therasse, P
    Buyse, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S277 - S278
12345